Analyst Research

Report Title Price
Provider: Pechala's Reports
Provider: New Constructs, LLC
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bristol-Myers Squibb Co Reaffirms FY 2013 EPS Guidance

Thursday, 25 Apr 2013 07:30am EDT 

Bristol-Myers Squibb Co announced that for fiscal 2013, it confirms GAAP EPS guidance range of $1.54 to $1.64 and its non-GAAP EPS guidance range of $1.78 to $1.88. Both GAAP and non-GAAP guidance assume current exchange rates. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $1.83 for fiscal 2013. 

Company Quote

-4.75 -0.53%
22 Apr 2014